While drug-eluting stents are effective in keeping open diseased heart arteries, they should not be used for patients who need to have noncardiac surgery a short time after an interventional heart procedure. A presentation at the Society for Cardiovascular Angiography and Interventions in Orlando by cardiologists at Jefferson Medical College indicates that for these patients, bare metal stents provide a safer choice.
If you have some form of lung or cardiovascular disease, has your doctor told you how to check today’s “AQI”?and what to do if it’s over 100? Health care professionals should inform sensitive patients about the risks of exposure to air pollutants and recommend avoidance strategies for days when air quality is low, according to a special report in The American Journal of the Medical Sciences, published by the Southern Society for Clinical Investigation by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health.
Adults with high blood pressure and additional risk factors for heart disease may benefit more from taking one tablet rather than two, if their current treatment combines the lipid-lowering medication atorvastatin with the blood pressure-lowering medication amlodipine, researchers reported at the American Heart Association’s 8th Scientific Forum on Quality of Care and Outcomes Research in Cardiovascular Disease and Stroke.
Pretreatment with double-dose anticlotting medication just before percutaneous coronary intervention cuts the combined risk of heart attack and cardiac death by half, according to a study reported at the 30th annual Scientific Sessions of the Society for Cardiovascular Angiography and Interventions, May 9-12, 2007, in Orlando, Fla.
Professor Louis Appleby, the National Clinical Director for Mental Health explains why improvements in community care must continue and sets out a new phase of reform in mental health services in a report published.
Following the success of the psychological therapies pilot programme in Doncaster and Newham, Health Secretary Patricia Hewitt today announced new funding for a further ten pathfinder projects.
A recall has been issued for the VITROS Immunodiagnostic Products Troponin I Reagent Pack, a medical test used to diagnose heart attack or injury to the heart muscle. The recall refers specifically to lot numbers 3151 and 3170.
Fosamax, a leading osteoporosis drug, has been connected to problems with irregular heart rhythm. Along with Reclast, another bone-building drug, atrial fibrillation developed much higher in test groups that took the medications.
Yale Cancer Center physicians have presented clinical recommendations for the diagnosis and subsequent treatment of superior vena cava syndrome in this week?s issue of the New England Journal of Medicine.
Weight and blood pressure screenings, massage therapy specials, a biking and running workshop and free injury, foot and spinal screenings are among the many events the athletics and recreation department has planned for individuals of all fitness levels during Northwestern’s celebration of National Physical Fitness and Sports Month in May.